• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大安大略省原发性胆汁性肝硬化的人口统计学特征。

The demography of primary biliary cirrhosis in Ontario, Canada.

作者信息

Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, Milner R, Pappas S C, Rankin J, Wanless I R

机构信息

Department of Medicine, University of Toronto, Ontario, Canada.

出版信息

Hepatology. 1990 Jul;12(1):98-105. doi: 10.1002/hep.1840120116.

DOI:10.1002/hep.1840120116
PMID:2197212
Abstract

The demographics of primary biliary cirrhosis in Ontario, Canada, are described. Two hundred and twenty-five primary biliary cirrhosis patients were identified by 85 of 502 gastroenterologists (or internists) practicing in Ontario acute care hospitals that have 150 or more beds. Two hundred and six patients were verified as being antimitochondrial antibody-positive, resulting in an incidence of 3.26 per million per year and a prevalence of 22.39 per million. Questionnaire data were obtained on 88.5% of these patients. Twenty-nine percent of the patients were found to be asymptomatic. Geographical clustering and racial predisposition were not seen. No increase in breast cancer prevalence was noted. By the time the diagnosis of primary biliary cirrhosis was established, the patients had consulted a median number of 3.5 physicians. Fatigue was reported as the most disabling symptom. The diagnosis of primary biliary cirrhosis in patients referred from across the province of Ontario was independently confirmed by us, using standard criteria (antimitochondrial antibody testing and liver biopsy), and was found to be reliable.

摘要

本文描述了加拿大安大略省原发性胆汁性肝硬化的人口统计学特征。在安大略省拥有150张或更多床位的急症护理医院执业的502名胃肠病学家(或内科医生)中的85人,共识别出225例原发性胆汁性肝硬化患者。其中206例患者被证实抗线粒体抗体呈阳性,年发病率为每百万人口3.26例,患病率为每百万人口22.39例。对其中88.5%的患者获取了问卷调查数据。发现29%的患者无症状。未观察到地理聚集性和种族易感性。未发现乳腺癌患病率增加。在原发性胆汁性肝硬化确诊时,患者平均已咨询过3.5名医生。疲劳被报告为最具致残性的症状。我们使用标准标准(抗线粒体抗体检测和肝活检),对从安大略省全省转诊来的患者的原发性胆汁性肝硬化诊断进行了独立确认,发现该诊断是可靠的。

相似文献

1
The demography of primary biliary cirrhosis in Ontario, Canada.加拿大安大略省原发性胆汁性肝硬化的人口统计学特征。
Hepatology. 1990 Jul;12(1):98-105. doi: 10.1002/hep.1840120116.
2
What does the antimitochondrial antibody mean?抗线粒体抗体是什么意思?
Gut. 1982 Oct;23(10):814-8. doi: 10.1136/gut.23.10.814.
3
Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members.原发性胆汁性肝硬化患者亲属中的抗线粒体抗体:抗线粒体抗体是临床疾病所特有的,无症状家庭成员中不存在。
Hepatology. 1992 Oct;16(4):899-905. doi: 10.1002/hep.1840160408.
4
Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.
Gut. 1993 Apr;34(4):544-8. doi: 10.1136/gut.34.4.544.
5
Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.原发性胆汁性肝硬化中针对四种特定M2线粒体自身抗原的IgG和IgM自身抗体的频率
Hepatology. 1989 Oct;10(4):403-7. doi: 10.1002/hep.1840100402.
6
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.抗线粒体抗体阴性原发性胆汁性肝硬化:一种自身免疫性胆管炎的独特综合征。
Gut. 1994 Feb;35(2):260-5. doi: 10.1136/gut.35.2.260.
7
Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.通过蛋白质免疫印迹法和酶联免疫吸附测定评估免疫荧光显示的具有M2-M4模式的抗线粒体抗体的异质性。
Gut. 1988 Apr;29(4):440-7. doi: 10.1136/gut.29.4.440.
8
Is mitochondrial antibody diagnostic of primary biliary cirrhosis?线粒体抗体能否诊断原发性胆汁性肝硬化?
Gut. 1981 Feb;22(2):136-40. doi: 10.1136/gut.22.2.136.
9
Prediction of prognosis of primary biliary cirrhosis in Japan.日本原发性胆汁性肝硬化的预后预测
Liver. 1995 Apr;15(2):70-7. doi: 10.1111/j.1600-0676.1995.tb00110.x.
10
[Are antimitochondrial antibodies the invariable hallmark of primary biliary cirrhosis?].抗线粒体抗体是原发性胆汁性肝硬化的恒定标志吗?
Presse Med. 2014 Dec;43(12 Pt 1):1311-3. doi: 10.1016/j.lpm.2014.07.015. Epub 2014 Oct 3.

引用本文的文献

1
New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage.原发性胆汁性胆管炎无症状期发病机制的新认识。
World J Gastroenterol. 2023 Oct 7;29(37):5292-5304. doi: 10.3748/wjg.v29.i37.5292.
2
Roles of Non-Coding RNAs in Primary Biliary Cholangitis.非编码RNA在原发性胆汁性胆管炎中的作用
Front Mol Biosci. 2022 Jul 8;9:915993. doi: 10.3389/fmolb.2022.915993. eCollection 2022.
3
The latest research trends in primary biliary cholangitis: a bibliometric analysis.原发性胆汁性胆管炎的最新研究趋势:文献计量分析。
Clin Exp Med. 2023 Jun;23(2):347-355. doi: 10.1007/s10238-022-00825-0. Epub 2022 Apr 7.
4
Development of a Theoretically Informed Web-Based Mind-Body Wellness Intervention for Patients With Primary Biliary Cholangitis: Formative Study.为原发性胆汁性胆管炎患者开发基于网络的理论指导身心健康干预措施:形成性研究。
JMIR Form Res. 2021 Oct 8;5(10):e29064. doi: 10.2196/29064.
5
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.系统性红斑狼疮中的自身抗体靶向线粒体 RNA。
Front Immunol. 2019 May 10;10:1026. doi: 10.3389/fimmu.2019.01026. eCollection 2019.
6
Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.原发性胆汁性胆管炎疲劳的治疗:系统评价和荟萃分析。
Dig Dis Sci. 2019 Aug;64(8):2338-2350. doi: 10.1007/s10620-019-5457-5. Epub 2019 Jan 10.
7
Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study.原发性胆汁性胆管炎的流行病学及肝移植负担:一项回顾性队列研究。
CMAJ Open. 2018 Dec 21;6(4):E664-E670. doi: 10.9778/cmajo.20180029. Print 2018 Oct-Dec.
8
Primary biliary cholangitis: a comprehensive overview.原发性胆汁性胆管炎:全面概述。
Hepatol Int. 2017 Nov;11(6):485-499. doi: 10.1007/s12072-017-9830-1. Epub 2017 Nov 21.
9
Extrahepatic Manifestations of Primary Biliary Cholangitis.原发性胆汁性胆管炎的肝外表现。
Gut Liver. 2017 Nov 15;11(6):771-780. doi: 10.5009/gnl16365.
10
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.原发性胆汁性胆管炎女性发病率和男性死亡率的演变趋势
Sci Rep. 2016 May 19;6:25906. doi: 10.1038/srep25906.